Table 1.
Studies currently underway registered at clinicaltrials.gov for therapies reviewed in this article (accessed May 8, 2020)
Therapy | Registered trials |
---|---|
Lopinavir/ritonavir | 54 |
Hydroxychloroquine/chloroquine | 265 |
Remdesivir | 21 |
Favipiravir | 14 |
Convalescent plasma | 61 |
Tocilizumab | 41 |
Sarilumab | 13 |